椎基底动脉复合体梭形动脉瘤:单中心系列研究
该单中心回顾性研究分析了2006年3月至2017年2月收治的45例椎基底动脉梭形动脉瘤(FVBA)患者,39例(86.7%)获随访,中位随访28.8个月。12例(26.7%)接受侵入性治疗(血管内9例、手术3例),33例保守治疗。随访期间血管内组严重残疾或死亡(mRS 4-6)6例(66.7%),手术组1例(33%),保守组19例(63.3%);症状性动脉瘤患者恶化显著更频繁(p=0.030)。
要点
- 45例FVBA患者中17例(37.7%)无症状,14例(31.1%)表现为脑干缺血,8例(17.8%)幕上缺血,3例(6.7%)脑干受压。
- 12例(26.7%)接受侵入性治疗(血管内9例、手术3例),33例保守治疗。
- 随访期间严重残疾或死亡(mRS 4-6):血管内组6例(66.7%),手术组1例(33%),保守组19例(63.3%)。
核心结论
- FVBA患者常因多种病理机制出现致残症状,自然病史具有侵袭性,尤其对于初始即有症状的动脉瘤,手术或血管内治疗的围手术期并发症发生率仍较高。
研究设计与样本
- 单中心回顾性研究,连续纳入2006年3月至2017年2月在该机构诊断的45例FVBA患者,回顾性评估临床表现、治疗过程和结局。
主要发现
- 45例连续患者中,17例(37.7%)无症状,14例(31.1%)表现为脑干缺血,8例(17.8%)幕上缺血,3例(6.7%)脑干受压;3例(6.7%)就诊时动脉瘤破裂。
- 初始时19例(42.2%)mRS评分≥3分,存在显著残疾;12例(26.7%)接受侵入性治疗(血管内9例、手术3例),33例保守治疗。
- 39例(86.7%)获得随访,中位随访28.8个月;随访期间严重残疾或死亡(mRS 4-6)事件:血管内组6例(66.7%),手术组1例(33%),保守治疗组19例(63.3%)。
- 症状性动脉瘤患者恶化显著更频繁(p=0.030)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fusiform vertebrobasilar aneurysms (FVBAs) may exhibit a disastrous clinical course. Due to their rare occurrence, evidence concerning optimal management is lackluster. OBJECTIVE: To describe the epidemiology, clinical features and treatment outcomes of a consecutive series of patients admitted to our institution. METHODS: We retrospectively evaluated patient charts with respect to clinical presentation, treatment procedures, and the outcomes of all patients diagnosed with an FVBA, which were seen at our institution between March 2006 and February 2017. RESULTS: Forty-five consecutive patients were analyzed. Follow-up was available for 39 patients (86.7%) with a median duration of 28.8 months. Seventeen patients (37.7%) were asymptomatic, 14 patients (31.1%) presented with brainstem ischemia, 8 patients (17.8%) with supratentorial ischemia, and 3 (6.7%) patients with brain stem compression. Aneurysm rupture occurred in 3 patients upon presentation (6.7%). Initially, 19 patients (42.2%) were significantly disabled with Modified Rankin Scale (mRS) scores ≥ 3. Twelve patients (26.7%) underwent invasive treatment: endovascular therapy in 9 cases and surgical treatment in 3 cases. Thirty-three patients received conservative treatment. During follow-up, 6 events (66.7%) of severe disability or death (mRS 4-6) occurred in the endovascular group versus 1 event (33%) in the surgical group versus 19 events (63.3%) among conservatively treated aneurysms. Deterioration was significantly more frequent in patients with symptomatic aneurysms (p = 0.030). CONCLUSION: Patients harboring an FVBA frequently present with disabling symptoms caused by various pathomechanisms. The natural history is aggressive, mostly for initially symptomatic aneurysms, and periprocedural morbidity of surgical or endovascular treatment remains substantial.
引用
- Wagner A, Prothmann S, Hedderich D, et al. Fusiform aneurysms of the vertebrobasilar complex: a single-center series. Acta Neurochir (Wien). 2020. PMID: 32248295. doi:10.1007/s00701-020-04304-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。